ArticleClinical Medicine Insights. Oncology2026

Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis.

Zexian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.